Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL + AP versus AL + placebo for uncomplicated falciparum malaria in African children
ISRCTN14750348Phase 3Completed
- Sponsor
- Kwame Nkrumah University of Science and Technology
- Start
- Jan 2022
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of artemether, lumefantrine, atovaquone, proguanil and Placebo-COD Research Private Ltd in Malaria, sponsored by Kwame Nkrumah University of Science and Technology. Started Jan 2022; status: completed.
02
Drugs
artemetherlumefantrineatovaquoneproguanilPlacebo-COD Research Private Ltd
03
Conditions
Malaria
Beyond the preview
Go deeper on ISRCTN14750348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14750348.